Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track EWTX with free AI briefings, catalyst countdowns, and dilution alerts.

EWTX

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$72.3M Cash on Hand

5.1mo Cash Runway

12.8% Short Interest

🧪 Upcoming Trial Catalysts

2026-09-01 · Phase 2 — Active Trial — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
2027-01-01 · Phase 2 — Active Trial — A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
2027-03-01 · Phase 2 — Active Trial — Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Pre
2027-12-01 · Phase 2 — Active Trial — A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
2031-02-01 · Phase 2 — Enrolling — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy

📊 Drug Pipeline

Drug	Indication	Phase	Status
Sevasemten Dose 5	Duchenne Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten Dose 4	Duchenne Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
EDG-7500	Hypertrophic Cardiomyopathy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten Dose 3	Duchenne Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten Dose 2	Duchenne Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten Dose 1	Duchenne Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten 10 mg	Becker Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten 12.5 mg	Becker Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Sevasemten 5 mg	Becker Muscular Dystrophy	PHASE2	ACTIVE_NOT_RECRUITING
Verapamil	Healthy Subjects	PHASE1	COMPLETED

💰 Cash Runway & Dilution Risk

EWTX holds $72.3M in cash and burns about $42.5M/quarter from operations, giving an estimated runway of 5.1 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for EWTX free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-08-14	Derakhshan Behrad	Purchase	$0
2026-08-14	Derakhshan Behrad	Purchase	$0
2026-08-14	Derakhshan Behrad	Sale	$1.5M
2026-08-14	Derakhshan Behrad	Sale	$1.5M
2026-08-14	Derakhshan Behrad	Sale	$1.5M

Get the full EWTX picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for EWTX and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z